30 November 2002
Predicting the Grade of Banff 97 Classification of Chronic Allograft Nephropathy Based on Examination of Graft Dysfunction (a Preliminary Report)O Schück, O Viklický, L Voska, S Vítko, V Teplan, J Lácha, A Jabor, J Skibová, M Štollová
Ann Transplant 2003; 8(3): 5-7 :: ID: 7519
Objectives: Progression of chronic allograft nephropathy (CAN) is associated with a progressive decrease in graft function. Prediction of the Banff CAN grade on the basis of correlation between the grade of histological changes and Scr is difficult because of the big spread of individual values. This study sought to predict the Banff CAN grade based on Scr, Ccr and proteinuria using ROC analysis. Methods: Graft protocol biopsy and functional testing (Scr, Ccr and proteinuria) were performed in 77 subjects (43 men, 34 women, mean age 48.4±12.8 years) at 33.8±1.0 months after their first renal transplantation. Immunosuppression was provided with the triple combination of cyclosporin A, prednisone and azathioprine (or mycophenolate mofetil). Statistical evaluation was performed using receiver-operating curve (ROC) analysis. The cut-off value of the Banff CAN score was set at 1. Results: The mean values and SD of the investigated functional parameters in study subjects were as follows: Scr = 201.5 (±100.0) µmol/l Ccr = 48.1 (±21.2) ml/min/1.73 m2, proteinuria = 0.89 (±1.96) g/24 h. ROC analysis showed the highest AUC (±SEM) for Scr 0.806 (±0.063). The respective values were 0.790 (±0.053) for Ccr and 0.643 (±0.075) for proteinuria. The AUC (area under the ROC curve) for Scr was significantly higher (P275 µmol/l and Ccr
17 May 2023 : Original articleResults of Liver Retransplantation After Rescue Hepatectomy: A Single-Center Study
Ann Transplant In Press; DOI: 10.12659/AOT.939557
10 May 2023 : Case reportOutcomes from a Single Transplant Center of 5 Pediatric Cases of Domino Liver Transplantation from Live Don...
Ann Transplant In Press; DOI: 10.12659/AOT.939893
Most Viewed Current Articles
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case reportCombined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...
Ann Transplant 2022; 27:e935860